Diabetes Prime Time: Glycemic Variability, Continuous Glucose Monitoring, and Postprandial Glucose Management
Release Date: December 3, 2019
Last Reviewed: November 7, 2019
Expiration Date: December 3, 2020
Time to Complete Activity: 1.0 hour

*This activity expired for credit on December 3, 2020 and is no longer available for credit

Jeff Unger, MD, FAAFP, FACE
Assistant Clinical Professor of Family Medicine
UC Riverside School of Medicine
Diplomate, American Board of Family Practice
Fellow, American Association of Clinical Endocrinologists
Director, Unger Concierge Primary Care Medical Group
Rancho Cucamonga, CA
Wendy S. Lane, MD
Clinical Endocrinologist
Director of Clinical Research
Mountain Diabetes and Endocrine Center
Asheville, NC
Javier Morales, MD, FACP, FACE
Associate Clinical Professor
Donald and Barbara Zucker School of Medicine
Hofstra Northwell University
Hempstead, NY
Vice President
Advanced Internal Medicine Group, PC
East Hills, NY
Contributing Faculty
Tim Moss

Corona, CA
This activity is provided by Paradigm Medical Communications, LLC. 

Target Audience
This activity has been designed to address the educational needs of primary care clinicians (family practice physicians, internal medicine physicians, nurse practitioners, PAs). It may also benefit other clinicians interested in the management of patients who use insulin to manage diabetes.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
• Evaluate the implications of glycemic variability (GV) for patients with diabetes
• Assess the utility of continuous glucose monitoring (CGM) for patients with diabetes
• Develop insulin treatment strategies to address postprandial glucose (PPG) excursions for patients with diabetes
Table of Contents
• Identifying glycemic variability
• Comparing GV and A1c and consequences of GV
• Managing postprandial glucose excursions 
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Commercial Support
This activity is supported by an educational grant from Novo Nordisk Inc.
Instructions for Participation
To receive a CME certificate of participation, you should:
• Follow instructions to register or log in with your professional information and complete the preactivity assessment
• View the online activity in its entirety
• Complete and submit the online posttest and evaluation.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Adobe Reader
The additional resource in this activity is in Adobe Acrobat PDF format. To view the resource, you will need Adobe Reader. If you do not have Adobe Reader installed on your computer, please visit http://get.adobe.com/reader/ to install a free version of Adobe Reader.
Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Jeff Unger, MD, FAAFP, FACE
Consulting Fees: Abbott Laboratories; Novo Nordisk Inc.
Speaker Bureau: sanofi-aventis U.S. LLC
Ownership interest: Novo Nordisk Inc.
Royalty: Lippincott Williams & Wilkins
Wendy S. Lane, MD
Grant/Research Support: Dexcom, Inc.; Lexicon Pharmaceuticals, Inc.; Novo Nordisk Inc.; sanofi-aventis U.S. LLC
Retained Consultant: Insulet Corporation; Novo Nordisk Inc.
Speakers Bureau: Dexcom, Inc.; Insulet Corporation; Novo Nordisk Inc.
Javier Morales, MD, FACP, FACE
Retained Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Novo Nordisk Inc.
Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Novo Nordisk Inc.
Tim Moss
No financial relationships to disclose.
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Peer reviewer, Carol Levy, MD, CDE has the following relationships to disclose:
Retained Consultant: sanofi-aventis U.S. LLC
Salary (Spouse): Allergan, Inc
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
© 2019 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.